Azithromycin targets bacterial protein synthesis. Specifically, it binds to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth. This leads to bacterial cell death.
Ciprofloxacin, on the other hand, inhibits bacterial DNA replication. It achieves this by blocking the action of bacterial topoisomerases, enzymes crucial for unwinding and supercoiling DNA during replication. This interruption prevents bacterial DNA replication and repair, ultimately killing the bacteria.
Therefore, while both are effective antibiotics, they work through distinct mechanisms. Azithromycin interferes with protein synthesis, whereas ciprofloxacin disrupts DNA replication. Understanding this difference is vital for selecting the appropriate antibiotic based on the infecting organism and its susceptibility profile.
